Forward Pharma A/S P/E Ratio

Forward Pharma A/S (FWP) currently reports a P/E ratio of 2166.67. That is above the Healthcare sector average of 27.22. Use the charts on this page to explore Forward Pharma A/S's P/E ratio history and peer comparisons.

Forward Pharma A/S's P/E ratio of 2166.67 is higher than the Healthcare sector average of 27.22. That is roughly 7860.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Forward Pharma A/S's market price to a fundamental measure such as earnings, sales, or book value. At 2166.67, FWP can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of 2166.67, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 27.22. From there, open related valuation or income-statement pages for Forward Pharma A/S, and consider following FWP for alerts when major investors trade the stock.

Forward Pharma A/S is classified in the Healthcare sector. On P/E ratio, it currently shows 2166.67 versus a sector average near 27.22. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FWP with unrelated industries.